Sprint 2

Sprint report for DHSC PIM Sprint 2

Carrot

What we did last week

  • Add tools for downloading and ingesting public PARD data
  • Compare the attributes required for each use case to what’s provided per data source
  • Data flows workshop with MHRA
  • Document the MHRA data schema
  • Understand issues with PARD data governance

What we’re planning to do this week

  • Acceptance criteria for design briefs
  • Content: Explore how the service could be maintained and improved in the future
  • Define research plan for User Research in sprint 2
  • Document attempts to match MHRA data directly with GUDID
  • Investigate quality issues with field validations in the MHRA dataset
  • Investigate tech in Trust-hosted PIMS, such as Atrify, Elcom, GHX.
  • Iterate prototypes - search
  • Recommend iterations for prototypes based on research outputs
  • Research - investigate what information trusts are asking manufacturers for

Goals

We have these goals this sprint (two-week period):

  • Given current knowledge about ALPHA assumption - agree clarity on ROADMAP In progress
  • Widen our participant pool In progress

Things to bear in mind

  • We are currently discussing changes to the roadmap and possibly the lenght of the project in light of things that we’ve discovered through explorations of data and user research

These are are currently identified risks and issues

  • /[Issue/] 13 fields may not be enough to provide value and / or solve the whole problem.
  • /[Issue/] Different people building different overlapping systems
  • /[Risk/]Final ownership
  • /[Risk/] Getting service assessment booked
  • /[Risk/] Lack of Engagement from manufacturers in a maintenance process
  • /[Risk/] NHS trust infrastructure to be able to consume data from PIM
  • /[Risk/] PIM is an infrastructure that underpins multiple services - how do we frame what PIM is. What does “End-to-end” mean is this situation.
  • /[Risk/] Quality of Data - beyond our control
  • /[Risk/]User availability
  • /[Risk/] What constitutes a medical device? How can we decide what is included and excluded from PIM